1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow Refractory Hematologic Malignancy: new trials by email Literature Review of Refractory Hematologic Malignancy trials Research Report on Refractory Hematologic Malignancy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Flotetuzumab for the Treatment of Relapsed or Refractory Advanced CD123-Positive Hematological Malignancies Acetaminophen, Dexamethasone, Diphenhydramine - Recurrent Acute Leukemia, Recurrent B Acute Lymphoblastic Leukemia | Phase 1 | Completed | City of Hope Medical Center | 13 | 2020-11-18 | 2026-01-28 |
Blastic Plasmacytoid Dendritic Cell Neoplasm (1) · Burkitt Lymphoma (1) · Hematologic Neoplasms (1) · Hodgkin Disease (1) · Leukemia, Hairy Cell (1) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1) · Mastocytosis, Systemic (1) · Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (1)
Bone Marrow Diseases (1) · Chronic Disease (1) · DNA Virus Infections (1) · Disease Attributes (1) · Epstein-Barr Virus Infections (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Herpesviridae Infections (1) · Histiocytic Disorders, Malignant (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Infections (1) · Leukemia (1) · Leukemia, Lymphoid (1) · Leukemia, Myeloid (1)
Acetaminophen (1) · Calcium Dobesilate (1) · Dexamethasone (1) · Diphenhydramine (1) · Ibuprofen (1) · Ranitidine (1) · auricularum (1) · dexamethasone 21-phosphate (1) · dexamethasone acetate (1)
City of Hope Medical Center (1)
United States (1)
Ibrahim T Aldoss (1)
P30CA033572 (1)